The ABCs of ADCs: Ovarian Cancer and Antibody Drug Conjugates

Antibody-drug conjugates (ADCs) are an exciting addition to ovarian cancer treatment. New treatments for ovarian cancer bring hope, but they also raise questions for patients. Dr. Jill Alldredge, discusses what an ADC is, the ins and outs of the first and only one currently approved for ovarian cancer, and any promising ADCs in the pipeline.
Advocate for your health and stay informed by subscribing to our RUclips channel. Activate the notifications so you don’t miss any of our upcoming ovarian cancer webinars.
▶️ Presenter: Dr. Jill Alldredge, Gynecologic Oncologist at UCHealth
▶️ Access our free services about ovarian cancer at: sharecancersupport.org/ovarian-cancer/
▶️ Subscribe to our newsletter: sharecancersupport.org/newsletter/
▶️ Learn from our ovarian cancer experts in our playlist: bit.ly/4crv97W
▶️ Follow us on social media:
Instagram: sharecancersupport
Facebook: SHARECancerSupport
LinkedIn: linkedin.com/company/share-cancer-support/
#ovariancancer #ovariancancerresearch #ovariancancerawareness #antibodytest #Antibodydrugconjugates #adcforovariancancer